Tirzepatide The Woodlands, TX
US$ 28.88
nasm glp 1 survey reveals GLP-1 weight-loss drugs like Ozempic and Wegovy are reshaping fitness coaching, with 60% of pros reporting clients losing muscle mass rather than fat. Trainers must now emphasize resistance training, NASM survey reveals GLP-1 weight-loss
Description
Patients typically experience a 15-20% reduction in weight.
Includes MHRA Yellow Card reporting guidance.
GLP-1 medications like semaglutide and tirzepatide are FDA-approved treatments that support sustainable weight loss by regulating appetite, improving insulin sensitivity, and addressing metabolic challenges.
Most recently on 8 November 2023, the US Food and Drug Administration approved through an expedited process the use of tirzepatide (Zepbound®) for chronic weight management in adults with obesity, reflecting the urgent need to address gaps in obesity treatment
Bundle Features
Is it possible to summarize the outcomes of that trial?
